First Phase 3 Trial of Safety and Efficacy of luliconazole in Patients With Tinea pedis.
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2018
Price : $35 *
At a glance
- Drugs Luliconazole (Primary)
- Indications Tinea pedis
- Focus Registrational; Therapeutic Use
- Sponsors Bausch Health Companies; Valeant Pharmaceuticals International
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 20 May 2014 New trial record